Panacea Bio Chem — the company behind CryoSurge, founded by Bogdan Dicoias CryoSurge™

Panacea Bio Chem · Technology dossier · CryoSurge

Nucleation-Induced Crystallisation Exotherm

CRYOSURGE™ — When Ice Nucleates, Temperature Speaks.

From the first crystallisation exotherm to intelligent annealing, CryoSurge transforms the observed thermal response of a freezing formulation into measurable process landmarks and actionable control information.

Product temperature · DCSA · illustrationswipe the chart ↔ · Lyochrysalis · S3Pulse
Illustration of the CryoSurge-guided DCSA sequence Product temperature against schematic time. Commanded cooling to minus 18 degrees; CryoSurge onset at minus 18; the natural exotherm lifts the product to minus 12; commanded cooling back to minus 18; DCSA warms the product under control to minus 12; annealing hold; final freeze to minus 40 degrees. 0°−10°−20°−30°−40°TANNEAL = TCPTREVERSAL = TCS time (schematic) → product temperature, °C TCS onset −18 °CTCP natural peak −12 °CTCR return to onsetannealing holdULT target −40 °C
Product temperature−40.0 °CFrozen: ready for primary drying
  • Natural CryoSurge excursion (latent heat)
  • Commanded cooling
  • Commanded warming and hold (DCSA)
Illustration, not a recorded trace: the CryoSurge-guided DCSA sequence drawn with the example figures Bogdan Dicoias gave for it (onset −18 °C, natural peak −12 °C, final ULT target −40 °C). The time axis is schematic.

Direct answer

CryoSurge™ is Panacea Bio Chem’s name for the nucleation-induced crystallisation exotherm: when a supercooled formulation starts to freeze, the latent heat of the forming ice lifts the product’s own temperature. On the Lyochrysalis research platform each product holder carries its own temperature probe, and S3Pulse records the event as three landmarks — onset, peak and return.

Dicoias CryoSurge Smart Annealing (DCSA) uses those landmarks to steer the freeze that follows, and Dicoias CryoSurge Smart Nucleation (DCSN) can trigger the nucleation itself, on demand.

Bogdan Dicoias — biochemist and inventor, Director of Panacea Bio Chem, the inventor of CryoSurge detection, DCSN and DCSA

Bogdan Dicoias

Biochemist and inventor · Director, Panacea Bio Chem

CryoSurge detection, DCSN and DCSA were invented by Bogdan Dicoias and are developed at Panacea Bio Chem on the Lyochrysalis research platform, under S3Pulse control. dicoias.com

“THE PRODUCT TELLS US WHEN IT FREEZES. OUR MACHINE LISTENS — AND ACTS.”

Bogdan Dicoias, April 2025 — the principle behind CryoSurge

From observing freezing to engineering with it

01Nucleation is not a footnote in the log

At Panacea Bio Chem, nucleation is not merely a temperature event buried in a freeze-drying log. Our Lyochrysalis research platform measures the product’s own thermal response, while S3Pulse records the CryoSurge nucleation landmark and the natural warming that follows. Dicoias CryoSurge Smart Annealing extends this approach into a control strategy: using the formulation’s observed freezing response to define a subsequent controlled annealing trajectory before final deep freezing. Annealing on the way down, without first freezing to −40 °C and warming back up, is Bogdan Dicoias’s invention, and he is the first to implement it in a machine. The engineering objective is to turn those observations into reproducible, instrument-governed process decisions.

Others describe the phenomenon. We built an instrumented platform that observes it, and we develop hardware-linked control around it.

02Three landmarks, read from the product itself

CryoSurge Onset

TCS

The product temperature at detected nucleation onset: the deepest point of supercooling, the instant ice appears.

CryoSurge Peak

TCP

The maximum credible product temperature during the natural crystallisation exotherm, as latent heat lifts the product.

CryoSurge Return

TCR

The subsequent return towards the onset temperature, as the cooling takes over from the released heat.

Same temperature, different state. Before nucleation, −18 °C describes a supercooled liquid; after it, −18 °C describes ice and freeze-concentrated liquid side by side. A thermometer reading alone cannot tell the two apart, so S3Pulse reads the event, not just the number. The phenomenon in full →

03The CryoSurge platform: the product tells us when it freezes

Our thesis is simple to state and demanding to build: a freezing formulation reports its own crystallisation, and a machine that listens can act on that report instead of on a fixed recipe temperature. CryoSurge detection, DCSN and DCSA are our own technologies, invented by Bogdan Dicoias and built in-house into S3Pulse, the control system of the Lyochrysalis research platform.

The ultimate goal is a freeze-drying process set by the product itself: every freeze timed from its own CryoSurge, holder by holder, with no energy spent on a round trip to −40 °C.

04Why anneal before the deep freeze: cost, time and energy

A conventional annealing step comes after the product has been frozen: the frozen load is warmed to a set annealing temperature, held there and refrozen (Searles et al. 2001, PMID 11458336). DCSA places the annealing where the formulation has just announced its own crystallisation, before the deep freeze. Choose a route to see what each one asks of the machine.

Three routes · same nucleation · same annealing temperature · swipe ↔
Three freezing routes compared (illustration) Conventional freeze to minus 40; conventional annealing that freezes to minus 40, warms to minus 12, holds and refreezes; DCSA that cools back to minus 18 after the CryoSurge peak, warms to minus 12, holds and then freezes once to minus 40. 0°−10°−20°−30°−40°product temperature, °Ctime (schematic) →
  • Conventional freeze: straight to −40 °C
  • Conventional annealing: after the deep freeze
  • DCSA: at the product’s own peak
Commanded cooling
54 °C
Commanded heating
6 °C
Extra travel beyond a straight freeze
12 °C
Illustration with the example figures given by Bogdan Dicoias: the same nucleation and the same annealing temperature (−12 °C) in every route, so only the route differs. The numbers are degrees of temperature travel along each curve.

That is the engineering rationale behind DCSA: fewer degrees of refrigeration and reheating, a shorter freeze stage, less energy and less machine time per batch.

Annealing also changes the drying that follows, and the literature shows why the comparison has to measure it: annealing raised primary drying rates up to 3.5-fold in one study (Searles et al. 2001, PMID 11458336), while in another it halved the desorption kinetics of secondary drying (Chouvenc et al. 2006, PMID 16696192). The evidence, kept in its classes →

05Listening, then acting: DCSN and DCSA

Nucleation on demand

DCSN — Dicoias CryoSurge Smart Nucleation

An on-demand, time-metered gas pulse with a mechanical burst forces nucleation at a chosen product temperature, replacing random supercooling with a deterministic, operator-triggered event. S3Pulse stores each formulation’s CryoSurge, so a later run can fire the burst ahead of it. DCSN →

Annealing guided by the product

DCSA — Dicoias CryoSurge Smart Annealing

TANNEAL = TCP and TREVERSAL = TCS, with no arbitrary offset. The product is cooled back to its own onset, warmed under control to its own natural peak, held, and only then taken to the final ULT target. DCSA →

06What is implemented, tested and validated

ElementStatusWhere it stands
CryoSurge on the LyochrysalisValidatedRecorded since early 2025 and named CryoSurge in February 2026; on the Lyochrysalis, holder by holder (S3Pulse learning record).
Detection and per-holder recordingImplementedS3Pulse reads each holder’s probe and records onset, peak and return.
DCSN, nucleation on demandImplementedNucleation bursts on the machine since March 2026; named DCSN and rebuilt in May 2026.
CryoSurge-guided DCSAImplementedImplemented in S3Pulse and tested end to end, every command through the Actuator Authority with relay readback.

Frequently asked

What is CryoSurge?

CryoSurge™ is Panacea Bio Chem’s name for the nucleation-induced crystallisation exotherm: the moment a supercooled formulation starts to freeze, the latent heat of the forming ice lifts the product’s own temperature. On the Lyochrysalis research platform S3Pulse records it, holder by holder, as three landmarks: onset, peak and return.

Is CryoSurge the same as cryosurgery?

No. Cryosurgery is the medical use of extreme cold to destroy tissue. CryoSurge™ is a freeze-drying term: the temperature rise a freezing formulation shows when ice nucleates, and the Panacea Bio Chem technology that reads it.

What are TCS, TCP and TCR?

The three CryoSurge landmarks. TCS, the CryoSurge Onset, is the product temperature at detected nucleation onset; TCP, the CryoSurge Peak, is the maximum credible product temperature during the natural crystallisation exotherm; TCR, the CryoSurge Return, is the subsequent return towards the onset temperature.

What is DCSA?

Dicoias CryoSurge Smart Annealing. After the CryoSurge, the product is cooled back to its own recorded onset, warmed under control to its own recorded natural peak, held there, and only then taken to the final ULT target: TANNEAL = TCP and TREVERSAL = TCS, with no arbitrary offset.

Is DCSA the same as conventional annealing?

No. Conventional annealing warms a load that is already deep-frozen to a temperature chosen in advance, holds it and refreezes it. DCSA anneals before the deep freeze and takes its targets from the product’s own recorded CryoSurge, never from a collapse or Tg′ figure; the formulation’s established limits still bound every move.

Does DCSA save energy and time?

Yes: annealing before the deep freeze avoids cooling the load to the ULT target, warming it back and cooling it again, so fewer degrees of refrigeration and reheating are spent and the freeze stage is shorter.

How is CryoSurge different from CryoFlare?

CryoSurge is a sudden rise in product temperature during freezing, when ice nucleates. CryoFlare is a sharp drop in product temperature during sublimation, an unwanted event. They belong to different stages and are never conflated.

Is the CryoSurge-guided sequence proven?

Yes. It is implemented in S3Pulse and tested end to end, every command through the Actuator Authority with relay readback.

What do you measure about visitors?

Only cookieless, privacy-by-design statistics: no cookies, no fingerprinting, no third-party trackers, no full referrers. IP addresses are kept only as daily-rotating salted hashes, so cross-day tracking is impossible by design, and the beacon honours Do Not Track.

Trending in the field

References

  1. Searles JA, Carpenter JF, Randolph TW. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. J Pharm Sci 2001;90(7):860-71. PMID 11458335
  2. Searles JA, Carpenter JF, Randolph TW. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. J Pharm Sci 2001;90(7):872-87. PMID 11458336
  3. Konstantinidis AK, Kuu W, Otten L, Nail SL, Sever RR. Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci 2011;100(8):3453-3470. PMID 21465488
  4. Rambhatla S, Ramot R, Bhugra C, Pikal MJ. Heat and mass transfer scale-up issues during freeze drying: II. Control and characterization of the degree of supercooling. AAPS PharmSciTech 2004;5(4):e58. PMID 15760055
  5. Patel SM, Bhugra C, Pikal MJ. Reduced pressure ice fog technique for controlled ice nucleation during freeze-drying. AAPS PharmSciTech 2009;10(4):1406-11. PMID 19937284
  6. Chouvenc P, Vessot S, Andrieu J. Experimental study of the impact of annealing on ice structure and mass transfer parameters during freeze-drying of a pharmaceutical formulation. PDA J Pharm Sci Technol 2006;60(2):95-103. PMID 16696192
  7. Kharatyan T, Gopireddy SR, Ogawa T, Kodama T, Nishimoto N, Osada S, Scherließ R, Urbanetz NA. Quantitative Analysis of Glassy State Relaxation and Ostwald Ripening during Annealing Using Freeze-Drying Microscopy. Pharmaceutics 2022;14(6):1176. PMID 35745749
  8. Wang J, Searles JA, Torres E, Tchessalov SA, Young AL. Impact of Annealing and Controlled Ice Nucleation on Properties of A Lyophilized 50 mg/ml MAB Formulation. J Pharm Sci 2022;111(9):2639-2644. PMID 35613684
  9. Kasper JC, Friess W. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur J Pharm Biopharm 2011;78(2):248-63. PMID 21426937
  10. Geidobler R, Winter G. Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review. Eur J Pharm Biopharm 2013;85(2):214-22. PMID 23643793
  11. Assegehegn G, Brito-de la Fuente E, Franco JM, Gallegos C. The Importance of Understanding the Freezing Step and Its Impact on Freeze-Drying Process Performance. J Pharm Sci 2019;108(4):1378-1395. PMID 30529167
  12. Supercooling, Wikipedia; Enthalpy of fusion, Wikipedia.

Concept: Bogdan Dicoias · Published by Panacea Bio Chem Scientific Communications · first edition, 4 November 2026 · Evidence last searched 4 November 2026 (PubMed) — every study cited here was read from its PubMed record; first-party facts come from Panacea Bio Chem’s S3Pulse records.

Panacea Peptides · Panacea Bio Chem · Bogdan Dicoias · Panacea Technologies — CryoSurge detection, DCSN and DCSA are technologies invented by Bogdan Dicoias at Panacea Bio Chem.

Panacea IQP — the Interactive Query Portal by Panacea Bio Chem, Bogdan DicoiasPanacea IQP — Interactive Query Portal ↗

The Panacea Technology Universe

26 technologies, each the leader of its class

Proprietary Panacea Bio Chem Ltd technologies, invented by Bogdan Dicoias — what each one does, and why it leads its class.

Lyoprester® technology convergence — the Panacea Bio Chem technologies that meet inside one cartridge, invented by Bogdan Dicoias
Lyoprester® — Panacea Bio Chem technology by Bogdan DicoiasLyoprester®The only dual-chamber cartridge that is autoreconstitution-enabled, vacuum-sealed and argon-fillback.lyoprester.com ↗P-EARLs — Panacea Bio Chem technology by Bogdan DicoiasP-EARLs™Panacea-Engineered Aseptic Reconstitution Liquid(s) — each tuned to the peptide it wakes.p-earls.com ↗Peptourbillon — Panacea Bio Chem technology by Bogdan DicoiasPeptourbillon™The layered peptide formulation architecture — single- or multi-layer, never a blend.peptourbillon.com ↗RF Tunnel — Panacea Bio Chem technology by Bogdan DicoiasRF Tunnel™The RF-formed central channel through the cake.rftunnel.com ↗TgShift — Panacea Bio Chem technology by Bogdan DicoiasTgShift™Raises the cake’s glass-transition temperature with RF — instead of chilling below it.tgshift.com ↗Cryolapse — Panacea Bio Chem technology by Bogdan DicoiasCryolapse™Cryogenic pressure collapse under S3Pulse™ control — vapour redistributed through the whole cake, not its surface, impeding crust formation.cryolapse.com ↗LyoLevit — Panacea Bio Chem technology by Bogdan DicoiasLyoLevit™The cake levitates and spins in high orbit — driven by ultrasound and RF.lyolevit.com ↗Lyochrysalis — Panacea Bio Chem technology by Bogdan DicoiasLyochrysalis™The integrated chamber housing the whole drying stack.lyochrysalis.com ↗S3Pulse — Panacea Bio Chem technology by Bogdan DicoiasS3Pulse™The control brain for every piece of Panacea hardware.s3pulse.com ↗Liquiprester — Panacea Bio Chem technology by Bogdan DicoiasLiquiprester™The single-liquid cartridge engineered so multiple peptide APIs coexist in one shared vehicle.liquiprester.com ↗Syntheseract — Panacea Bio Chem technology by Bogdan DicoiasSyntheseract™Continuous-flow peptide synthesis in a special, very fast and economical way.syntheseract.com ↗CFSPPS — Panacea Bio Chem technology by Bogdan DicoiasCFSPPS™Continuous-flow solid-phase peptide synthesis, written as its own category.cfspps.com ↗OxyDeplete — Panacea Bio Chem technology by Bogdan DicoiasOxyDeplete™Degassing plus no-headspace doctrine — the oxygen-starved seal.oxydeplete.com ↗ArgonLock — Panacea Bio Chem technology by Bogdan DicoiasArgonLock™The final inert-atmosphere lock under argon.argonlock.com ↗RedoxVault — Panacea Bio Chem technology by Bogdan DicoiasRedoxVault™Separation, not merely suppression — redox isolation in lipid micro-reservoirs.redoxvault.com ↗PleniDose — Panacea Bio Chem technology by Bogdan DicoiasPleniDose™The shared filling gantry — one machine filling both the dual-chamber Lyoprester and the liquid Liquiprester.plenidose.com ↗IncreSure — Panacea Bio Chem technology by Bogdan DicoiasIncreSure™The dose-metrology layer — verified API per pen increment.incresure.com ↗ElimiVoid — Panacea Bio Chem technology by Bogdan DicoiasElimiVoid™Front-void elimination without touching the metered dose.elimivoid.com ↗Cryoviscous — Panacea Bio Chem technology by Bogdan DicoiasCryoviscous™The characterised cold, high-viscosity, low-mobility conditioning state.cryoviscous.com ↗Vana Machine — Panacea Bio Chem technology by Bogdan DicoiasVana Machine™Vacuum–Argon–Nitrogen Architecture — draws the air and nitrogen out of the cake and backfills with argon; in a separate process, the same machine makes the P-EARLs bubble-free.www.vanamachine.com ↗EZnject — Panacea Bio Chem technology by Bogdan DicoiasEZnject™The disposable auto-injector pen built around the Lyoprester.panaceaeznject.com ↗Dicoias Ψ — Panacea Bio Chem technology by Bogdan DicoiasDicoias ΨThe computed-chemistry advisory — every substance reduced to a vector across physical, electronic and formulation space.dcppsi.com ↗SealoPrester — Panacea Bio Chem technology by Bogdan DicoiasSealoPrester™Aseptic Cartridge Closure System — Seal o’ Precision + Sterility.sealoprester.com ↗Peptidic Liquid — Panacea Bio Chem technology by Bogdan DicoiasPeptidic LiquidThe peptide formulation in solution — the active plus its buffers, cryoprotectants, lyoprotectants and scaffolders.peptidicliquid.com ↗DiastolVAC — Panacea Bio Chem technology by Bogdan DicoiasDiastolVAC™Biomimetic diastolic vacuum control — the pneumatic circulatory system of the machine: pumps, valves and sensors as one ensemble.diastolvac.com ↗KineticON — Panacea Bio Chem technology by Bogdan DicoiasKineticON™Motion Integrity Architecture — the motion-control layer that lets the machine know what happened on every axis move.kineticon.org ↗

Weekly review — 9–15 Nov 2026

No publication indexed in PubMed in the last 30 days for ice nucleation, supercooling and annealing in freeze-drying — the most recent in the field, refreshed weekly.